STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) |
Common Stock [Member] |
Common Stock [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Additional Paid - In Capital Shares to Be Issued [Member] |
Additional Paid-in Capital [Member] |
Additional Paid-in Capital [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Accumulated Deficit [Member] |
Accumulated Deficit [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
|
Accumulated Deficit [Member]
Cumulative Effect Period Of Adoption Adjusted Balance [Member]
|
Total |
Cumulative Effect Period Of Adoption Adjustment [Member] |
Cumulative Effect Period Of Adoption Adjusted Balance [Member] |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning balance at Sep. 30, 2018 | $ 832,013 | $ 36,640,009 | $ (41,858,257) | $ (4,386,235) | |||||||
| Beginning balance (in shares) at Sep. 30, 2018 | 832,013,272 | ||||||||||
| Stock based compensation | 1,629,333 | 1,629,333 | |||||||||
| Warrants issued for term loans, net of capital costs | 5,090,470 | 5,090,470 | |||||||||
| Common stock and warrants issued in capital raise | $ 19,325 | 946,925 | 966,250 | ||||||||
| Common stock and warrants issued in capital raise (in shares) | 19,325,000 | ||||||||||
| Warrants issued for debt extension | 152,078 | 152,078 | |||||||||
| Warrants exercised in extinguishment of term loans, net of capital costs | $ 238,095 | 9,685,746 | 9,923,841 | ||||||||
| Warrants exercised in extinguishment of term loans, net of capital costs (in shares) | 238,095,238 | ||||||||||
| Common stock issued for exercise of Bridge Financing Note warrants | $ 2,833 | 82,167 | 85,000 | ||||||||
| Common stock issued for exercise of Bridge Financing Note warrants (in shares) | 2,833,334 | ||||||||||
| Common stock registration costs | (65,892) | (65,892) | |||||||||
| Net loss | (13,723,753) | (13,723,753) | |||||||||
| Ending balance at Sep. 30, 2019 | $ 1,092,266 | $ 1,092,266 | 54,160,836 | $ 54,160,836 | (55,582,010) | $ 16,431 | $ (55,565,579) | $ (328,908) | $ 16,431 | $ (312,477) | |
| Ending balance (in shares) at Sep. 30, 2019 | 1,092,266,844 | 1,092,266,844 | 1,092,266,844 | ||||||||
| Stock based compensation | 968,257 | $ 968,257 | |||||||||
| Common stock issued for conversion of note payable and accrued interest | $ 120,051 | 2,096,807 | 2,216,858 | ||||||||
| Common stock issued for conversion of note payable and accrued interest (in shares) | 120,050,281 | ||||||||||
| Warrants issued for debt extension | 19,300 | 19,300 | |||||||||
| Common stock issued to extinguish liability | $ 38,423 | 1,498,506 | 1,536,929 | ||||||||
| Common stock issued to extinguish liability (in shares) | 38,423,221 | ||||||||||
| Common stock registration costs | (15,398) | (15,398) | |||||||||
| Common stock to be issued to extinguish accrued interest | $ 105,000 | 105,000 | |||||||||
| Net loss | (2,416,092) | (2,416,092) | |||||||||
| Ending balance at Sep. 30, 2020 | $ 1,250,740 | $ 105,000 | $ 58,728,308 | $ (57,981,671) | $ 2,102,376 | ||||||
| Ending balance (in shares) at Sep. 30, 2020 | 1,250,740,346 | 1,250,740,346 |